Volume 28, Number 1—January 2022
Synopsis
Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India
Samir Joshi, Rahul Telang, Muralidhar Tambe, Rajesh Havaldar
, Manasi Sane, Afshan Shaikh, Cherry Roy, Kireet Yathati, Sanjaykumar Sonawale, Rupalee Borkar, Rahul Magar, Harshal Bhitkar, Satish Shitole, Leena Nakate, Jyoti Kudrimoti, and Vidya Mave
, Manasi Sane, Afshan Shaikh, Cherry Roy, Kireet Yathati, Sanjaykumar Sonawale, Rupalee Borkar, Rahul Magar, Harshal Bhitkar, Satish Shitole, Leena Nakate, Jyoti Kudrimoti, and Vidya Mave
Table 3
Sites of mucormycosis in patients with COVID-19 by severity and outcome of illness, Pune, India
| Site | COVID-19 severity, no. patients (%) |
Outcome, no. patients (%) |
|||||
|---|---|---|---|---|---|---|---|
| Mild, n = 29 | Moderate, n = 122 | Severe, n = 8 | Active, n = 5 | Discharged, n = 147 | Died, n = 26 | ||
| Unifocal, n = 71 | |||||||
| Localized sinus, n = 71 |
13 (45) |
51 (42) |
3 (37) |
2 (40) |
59 (40) |
10 (38) |
|
| Multifocal, n = 107 | |||||||
| Generalized, n = 52 | 5 (18) | 37 (30) | 3 (37) | 3 (60) | 38 (26) | 11 (42) | |
| Rhino-sinus, n = 6 | 3 (10) | 2 (2) | 1 (13) | 0 | 5 (3) | 1 (4) | |
| Rhino-orbital, n = 43 | 6 (21) | 30 (25) | 1 (13) | 0 | 41 (29) | 2 (8) | |
| Rhino-cerebral, n = 2 | 1 (3) | 0 | 0 | 0 | 2 (1) | 0 | |
| Rhino-orbito-cerebral, n = 4 | 1 (3) | 2 (2) | 0 | 0 | 2 (1) | 2 (8) | |
Page created: September 24, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.